Lupin Limited's recall of skin medicine comes after Indian medicines have been linked to over 100 deaths in Gambia and Uzbekistan.
On Thursday, The Central Drugs Standard Control Organisation (CDSCO) initiated a probe in connection with the death of 18 children in Uzbekistan allegedly linked to a cough syrup manufactured by an Indian firm, official...
Infosys founder N R Murthy also said experts feel that India’s inability to use research to solve immediate pressing problems is due to lack of inculcating curiosity at an early age, disconnect between pure and applied...
In December, the health ministry of Uzbekistan claimed that as many as 18 children have lost their lives in the country after consuming medicines manufactured by an Indian pharmaceutical company.
In a statement, the health ministry said the children who died had consumed the Dok-1 Max Syrup produced by Noida-based Marion Biotech. To date, 18 out of 21 children with acute respiratory disease have died as a result of...
As per media reports, the Haryana government has stopped their production after significant discrepancies were identified in manufacturing at the facilities of Maiden Pharmaceuticals.
Union Health Minister Mansukh Mandaviya said further action would be taken based on the inspection of the pharma company, under a cloud after the Uzbekistan health ministry's allegation that the children died after consuming...
The WHO warned that four 'contaminated' and 'substandard' cough syrups allegedly produced by Maiden Pharmaceuticals Limited based in Haryana's Sonepat could be the reason for the deaths in the West African nation.
